Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury
Phenylephrine Tumescence for Hemostasis in Surgery for Burn Injury - A Randomized Control Trial
University of Manitoba
24 participants
Dec 1, 2014
INTERVENTIONAL
Conditions
Summary
The standard of care for treatment of burn injury is to inject a solution of epinephrine under the skin of the injured site in order to reduce blood loss during skin grafting. This solution of epinephrine has been shown to have effects on the body outside the donor site. Some people have increases in heart rate and blood pressure. We will study the effect of a phenylephrine solution in place of an epinephrine solution to control blood loss. We think that phenylephrine will help decrease blood loss and not change blood pressure or heart rate. The injured area will be injected under the skin and a skin graft will be taken in the same way as we usually do. The only change will be the use of phenylephrine in the solution instead of epinephrine. Our goal is to find whether or not phenylephrine or epinephrine solution results in a reduction of blood loss without affecting the rest of the body.
Eligibility
Inclusion Criteria1
- a) Burn injury requiring debridement and grafting between 5-30% TBSA
Exclusion Criteria8
- Head and neck, hand, foot, or genital burns
- On anticoagulants (except NSAIDs)
- On monoamine oxidase inhibitor or tricyclic antidepressant
- Coronary or peripheral vascular disease
- History of arrhythmias
- On a Beta-blocker
- History of vascular abnormality
- Hypertension
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01731444